Collin Jugler retweetledi

🚨Excited to share our latest study on immunotherapy for prostate cancer, out today at @CellRepMed!
We hope this paves the way for further translation of Fc-enhanced CTLA-4 antibodies by showing evidence of tumor Treg depletion in patients.
cell.com/cell-reports-m…

English




